|
Talk to your sales representative to learn more.
|
|
United Therapeutics is committed
|
|
to patients beyond treatment.
|
|
TO ENROLL IN THIS PROGRAM, YOUR PATIENTS MUST UNDERSTAND AND AGREE TO COMPLY WITH THE ELIGIBILITY REQUIREMENTS AND TERMS OF USE.
|
| Eligibility Requirements for this program are: |
| • |
Patients must be 18 years or older to use this Program |
| • |
The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA-approved indication |
| • |
Patients using Medicare, Medicaid, or any other state or federal government program to pay for their medications are not eligible. Patients who start utilizing government coverage during the term of the Program will no longer be eligible |
| • |
Eligible patients must be residents of the US or Puerto Rico |
|
| Full Terms and Conditions will be available at program launch. |
|
|
|
|
|
This promotional communication is provided by United Therapeutics.
|
This message was sent to [email]. If you do not wish to receive e-mails
from United Therapeutics, please click here.
|
|
Please do not reply to this e-mail, as this is an unattended e-mail box.
|
Orenitram, Remodulin, and Tyvaso are registered trademarks of United Therapeutics Corporation.
|
|
© 2017 United Therapeutics Corporation. All rights reserved. US/RTO/0080.
|
|
